N-terminal pro-brain-type natriuretic peptide: A biochemical surrogate of cardiac function in the potential heart donor

European Journal of Cardio-thoracic Surgery

Volumn 38, Issue 2, 2010, Pages 181-186

  Dronavalli, Vamsidhar B ^a   Ranasinghe, Aaron M ^a,b   Venkateswaran, Rajamiyer J ^a   James, Sally R ^b   McCabe, Christopher J ^b   Wilson, Ian C ^a   Mascaro, Jorge G ^a   Bonser, Robert S ^a  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

BNP; Heart transplantation; NT proBNP; Organ donation

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; MESSENGER RNA; TROPONIN;

ADULT; AMINO TERMINAL SEQUENCE; ARTERY CATHETER; ARTICLE; BRAIN DEATH; FEMALE; GENE EXPRESSION; HEART FUNCTION; HEART HEMODYNAMICS; HEART INDEX; HEART INJURY; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE BIOPSY; HEART OUTPUT; HEART TRANSPLANTATION; HEART VENTRICLE; HEART VENTRICLE WALL; HUMAN; HUMAN TISSUE; LUNG FLUID; MAJOR CLINICAL STUDY; MALE; ORGAN DONOR; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PULMONARY ARTERY; PULMONARY ARTERY OCCLUSION PRESSURE; REAL TIME POLYMERASE CHAIN REACTION; TRANSTHORACIC ECHOCARDIOGRAPHY;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; BRAIN DEATH; CARDIAC OUTPUT; CAUSE OF DEATH; DONOR SELECTION; FEMALE; GENE EXPRESSION; HEART; HEART TRANSPLANTATION; HEART VENTRICLES; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; RNA, MESSENGER; STROKE VOLUME; TISSUE AND ORGAN HARVESTING; TISSUE DONORS; YOUNG ADULT;

EID: 77954386841     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2010.01.024     Document Type: Article

References (25)

1. De Lemos J.A., Morrow D.A. Use of natriuretic peptides in clinical decision-making for patients with non-ST-elevation acute coronary syndromes. Am Heart J 2007, 153:450-453.
2. Richards A.M., Nicholls M.G., Espiner E.A., Lainchbury J.G., Troughton R.W., Elliott J., Frampton C., Turner J., Crozier I.G., Yandle T.G. B-type natriuretic peptides and ejection fraction for prognosis after myocardial infarction. Circulation 2003, 107:2786-2792.
3. Richards A.M.., Nicholls M.G., Yandle T.G., Frampton C., Espiner E.A., Turner J.G, Buttimore R,C.., Lainchbury J.G., Elliott J.M., Ikram H., Crozier I.G., Smyth D.W. Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction. Circulation 1998, 97:1921-1929.
4. Sabatine M.S., Morrow D.A., De Lemos J.A., Omland T., Desai M.Y., Tanasijevic M., Hall C., McCabe C.H., Braunwald E. Acute changes in circulating natriuretic peptide levels in relation to myocardial ischemia. J Am Coll Cardiol 2004, 44:1988-1995.
5. James S.K., Lindahl B., Siegbahn A., Stridsberg M., Venge P., Armstrong P., Barnathan E.S., Califf R., Topol E.J., Simoons M.L., Wallentin L. N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease: a Global Utilization of Strategies To Open occluded arteries (GUSTO)-IV substudy. Circulation 2003, 108:275-281.
6. Lubien E., DeMaria A., Krishnaswamy P., Clopton P., Koon J., Kazanegra R., Gardetto N., Wanner E., Maisel A.S. Utility of B-natriuretic peptide in detecting diastolic dysfunction: comparison with Doppler velocity recordings. Circulation 2002, 105:595-601.
7. Krishnaswamy P., Lubien E., Clopton P., Koon J., Kazanegra R., Wanner E., Gardetto N., Garcia A., Anthony DeMaria, Maisel A.S. Utility of B-natriuretic peptide levels in identifying patients with left ventricular systolic or diastolic dysfunction. Am J Med 2001, 111:274-279.
8. Tung P.P., Olmsted E., Kopelnik A., Banki N.M., Drew B.J., Ko N., Lawton M.T., Smith W., Foster E., Young W.L., Zaroff J.G. Plasma B-type natriuretic peptide levels are associated with early cardiac dysfunction after subarachnoid haemorrhage. Stroke 2005, 36:1567-1569.
9. Yarlagadda S., Rajendran P., Miss J.C., Banki N.M., Kopelnik A., Wu A.H., Ko N., Gelb A.W., Lawton M.T., Smith W.S., Young W.L., Zaroff J.G. Cardiovascular predictors of in-patient mortality after subarachnoid hemorrhage. Neurocrit Care 2006, 5:102-107.
10. Nicolas-Robin A., Salvi N., Medimagh S., Amour J., Le Manach Y., Coriat P., Riou B., Langeron O. Combined measurement of N terminal pro-brain naturitic peptide and cardiac troponins in potential organ donors. Intensive Care Med 2007, 33:986-992.
11. Arden K.C., Viars C.A., Weiss S., Argentin S., Nemer M. Localization of the human B-type natriuretic peptide precursor (NPPB) gene to chromosome 1p36. Genomics 1995, 26:385-389.
12. Venkateswaran R.V., Steeds R., Quinn D.W., Nightingale P., Wilson I.C., Mascaro J.G., Thompson R.D., Townend J.N., Bonser R.S. The haemodynamic effects of adjunctive hormone therapy in potential heart donors: a prospective randomised double-blind factorially designed controlled trial. Eur Heart J 2009, 30:1771-1780.
13. Potter C.D., Wheeldon D.R., Wallwork J. Functional assessment and management of heart donors: a rationale for characterization and a guide to therapy. J Heart Lung Transplant 1995, 14:59-65.
14. Boelaert K., McCabe C.J., Tannahill L.A., Gittoes N.J., Holder R.L., Watkinson J.C., Bradwell A.R., Sheppard M.C., Franklyn J.A. Pituitary tumor transforming gene and fibroblast growth factor-2 expression: potential prognostic indicators in differentiated thyroid cancer. J Clin Endocrin Metabolism 2003, 88:2341-2347.
15. Espiner E.A., Leikis Rt, Ferch R.D., MacFarlane M.R., Bonkowski J.A., Frampton C.M., Richards A.M. The neuro-cardio-endocrine response to acute subarachnoid haemorrhage. Clin Endocrinol (Oxf) 2002, 56:629-635.
16. Wijdicks E.F., Schievink W.I., Burnett J.C. Natriuretic peptide system and endothelin in aneurysmal subarachnoid hemorrhage. J Neurosurg 1997, 87:275-280.
17. Riou B., Dreux S., Roche S., Arthaud M., Goarin J., Léger P., Saada M., Viars P. Circulating cardiac troponin T in potential heart transplant donors. Circulation 1995, 92:409-414.
18. Venkateswaran R.V., Ganesh J.S., Thekkudan J., Steeds R., Wilson I.C., Mascaro J., Thompson R., Bonser R.S. Donor cardiac troponin-I: a biochemical surrogate of heart function. Eur J Cardiothorac Surg 2009, 36:286-292.
19. Wagner F.D., Jonitz B., Potapov E.V., Qedra N., Wegscheider K., Abraham K., Ivanitskaia E.A., Loebe M., Hetzer R. Procalcitonin, a donor-specific predictor of early graft failure-related mortality after heart transplantation. Circulation 2001, 104:I-192-I-196.
20. Venkateswaran R.V., Dronavalli V., Peter A., Lambert, Steed R., Wilson I.C., Thompson R.D., Mascaro J.G., Bonser R.S. The proinflammatory environment in potential heart and lung donors: prevalence and impact of donor management and hormonal therapy. Transplantation 2009, 88(4):582-588.
21. Birks E.J., Burton P.B., Owen V., Mullen A.J., Hunt D., Banner N.R., Barton P.J., Yacoub M.H. Elevated tumour necrosis factor-alpha and interleukin-6 in myocardium and serum of malfunctioning donor hearts. Circulation 2000, 102:III-352-III-358.
22. Kantor H.L., Krishnan S.C. Cardiac problems in patients with neurologic disease. Cardiol Clin 1995, 13:179-208.
23. Zaroff J.G., Babcock W.D., Shiboski S.C. The impact of left ventricular dysfunction on cardiac donor transplant rates. J Heart Lung Transplant 2003, 22:334-337.
24. Rogers C.A., Ganesh J.S., Banner N.R., Bonser R.S. Cumulative risk adjusted monitoring of 30-day mortality after cardiothoracic transplantation: UK experience. Eur J Cardiothorac Surg 2005, 27:1022-1029. Steering Group.
25. Anderson J.R., Hossein-Nia M., Brown P., Holt D.W., Murday A. Donor cardiac troponin-T predicts subsequent inotrope requirements following cardiac transplantation. Transplantation 1994, 58:1056-1057.